[PHARMA] YoY Annual (Unaudited) Result on 31-Dec-2012 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
18-Feb-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
31-Dec-2012 [#4]
Profit Trend
YoY- 18.32%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annual (Unaudited) Result
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Revenue 2,189,312 2,122,933 1,946,639 1,812,346 1,520,981 1,378,348 1,300,796 9.06%
PBT 112,722 125,580 92,997 103,313 73,186 45,462 81,436 5.56%
Tax -28,138 -31,355 -36,236 -40,108 -20,401 -15,152 -19,709 6.11%
NP 84,584 94,225 56,761 63,205 52,785 30,310 61,727 5.38%
-
NP to SH 84,044 93,844 55,200 61,710 52,157 30,384 60,191 5.71%
-
Tax Rate 24.96% 24.97% 38.96% 38.82% 27.88% 33.33% 24.20% -
Total Cost 2,104,728 2,028,708 1,889,878 1,749,141 1,468,196 1,348,038 1,239,069 9.22%
-
Net Worth 529,482 525,526 486,754 471,886 514,273 421,524 431,158 3.48%
Dividend
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Div 77,674 72,486 41,477 41,187 35,304 10,698 39,585 11.88%
Div Payout % 92.42% 77.24% 75.14% 66.74% 67.69% 35.21% 65.77% -
Equity
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Net Worth 529,482 525,526 486,754 471,886 514,273 421,524 431,158 3.48%
NOSH 258,915 258,880 258,911 117,677 117,682 106,985 106,987 15.86%
Ratio Analysis
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
NP Margin 3.86% 4.44% 2.92% 3.49% 3.47% 2.20% 4.75% -
ROE 15.87% 17.86% 11.34% 13.08% 10.14% 7.21% 13.96% -
Per Share
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
RPS 845.57 820.05 751.85 1,540.10 1,292.44 1,288.35 1,215.84 -5.87%
EPS 32.46 36.25 21.32 52.44 44.32 28.40 56.26 -8.75%
DPS 30.00 28.00 16.02 35.00 30.00 10.00 37.00 -3.43%
NAPS 2.045 2.03 1.88 4.01 4.37 3.94 4.03 -10.68%
Adjusted Per Share Value based on latest NOSH - 117,715
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
RPS 151.91 147.30 135.07 125.75 105.53 95.64 90.26 9.05%
EPS 5.83 6.51 3.83 4.28 3.62 2.11 4.18 5.69%
DPS 5.39 5.03 2.88 2.86 2.45 0.74 2.75 11.86%
NAPS 0.3674 0.3646 0.3377 0.3274 0.3568 0.2925 0.2992 3.47%
Price Multiplier on Financial Quarter End Date
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Date 31/12/15 31/12/14 31/12/13 31/12/12 30/12/11 30/12/10 31/12/09 -
Price 6.36 4.58 4.45 8.10 5.36 5.31 4.00 -
P/RPS 0.75 0.56 0.59 0.53 0.41 0.41 0.33 14.65%
P/EPS 19.59 12.63 20.87 15.45 12.09 18.70 7.11 18.39%
EY 5.10 7.91 4.79 6.47 8.27 5.35 14.07 -15.55%
DY 4.72 6.11 3.60 4.32 5.60 1.88 9.25 -10.60%
P/NAPS 3.11 2.26 2.37 2.02 1.23 1.35 0.99 21.00%
Price Multiplier on Announcement Date
31/12/15 31/12/14 31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 CAGR
Date 15/02/16 23/02/15 24/02/14 18/02/13 22/02/12 25/02/11 19/02/10 -
Price 6.19 5.28 4.29 7.80 5.90 5.35 4.05 -
P/RPS 0.73 0.64 0.57 0.51 0.46 0.42 0.33 14.14%
P/EPS 19.07 14.57 20.12 14.87 13.31 18.84 7.20 17.61%
EY 5.24 6.87 4.97 6.72 7.51 5.31 13.89 -14.98%
DY 4.85 5.30 3.73 4.49 5.08 1.87 9.14 -10.01%
P/NAPS 3.03 2.60 2.28 1.95 1.35 1.36 1.00 20.28%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment